Incidence of rotavirus gastroenteritis hospitalizations and genotypes, before and five years after introducing universal immunization in Israel.

[1]  P. van Damme,et al.  Sustained low rotavirus activity and hospitalisation rates in the post-vaccination era in Belgium, 2007 to 2014. , 2016, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[2]  N. French,et al.  Early impact of rotavirus vaccination in a large paediatric hospital in the UK. , 2016, The Journal of hospital infection.

[3]  L. Rosella,et al.  Population-Level Impact of Ontario’s Infant Rotavirus Immunization Program: Evidence of Direct and Indirect Effects , 2016, PloS one.

[4]  D. Greenberg,et al.  Real-World Effectiveness of Pentavalent Rotavirus Vaccine Among Bedouin and Jewish Children in Southern Israel. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  Manish M Patel,et al.  Effectiveness of Pentavalent Rotavirus Vaccine Against a Diverse Range of Circulating Strains in Nicaragua. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  J. Tate,et al.  Global, Regional, and National Estimates of Rotavirus Mortality in Children <5 Years of Age, 2000-2013. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  A. Costello,et al.  Population Impact and Effectiveness of Monovalent Rotavirus Vaccination in Urban Malawian Children 3 Years After Vaccine Introduction: Ecological and Case-Control Analyses , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  J. Comeau,et al.  Impact of a publicly funded monovalent rotavirus vaccination program in the Province of Quebec (Canada). , 2016, Vaccine.

[9]  B. Standaert,et al.  Medium- to Long-Term Impact of Rotavirus Vaccination on Hospital Care in Belgium: A 7-Year Follow-Up of the Rotavirus Belgium Impact Study (RotaBIS) , 2015, Infectious Diseases and Therapy.

[10]  Dani Cohen,et al.  Change in incidence of clinic visits for all-cause and rotavirus gastroenteritis in young children following the introduction of universal rotavirus vaccination in Israel. , 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[11]  James A Singleton,et al.  National, State, and Selected Local Area Vaccination Coverage Among Children Aged 19-35 Months - United States, 2014. , 2015, MMWR. Morbidity and mortality weekly report.

[12]  Neff Walker,et al.  Estimating the herd immunity effect of rotavirus vaccine. , 2015, Vaccine.

[13]  L. Shulman,et al.  A significant and consistent reduction in rotavirus gastroenteritis hospitalization of children under 5 years of age, following the introduction of universal rotavirus immunization in Israel , 2015, Human vaccines & immunotherapeutics.

[14]  C. Atchison,et al.  Effectiveness and impact of rotavirus vaccines in Europe, 2006-2014. , 2015, Vaccine.

[15]  D. Greenberg,et al.  Rapid impact of rotavirus vaccine introduction to the National Immunization plan in southern Israel: comparison between 2 distinct populations. , 2015, Vaccine.

[16]  D. Muscatello,et al.  Impact of high coverage of monovalent human rotavirus vaccine on Emergency Department presentations for rotavirus gastroenteritis. , 2015, Vaccine.

[17]  J. Matthijnssens,et al.  Prevalence and genomic characterization of G2P[4] group A rotavirus strains during monovalent vaccine introduction in Brazil. , 2014, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[18]  U. Parashar,et al.  Review of global rotavirus strain prevalence data from six years post vaccine licensure surveillance: is there evidence of strain selection from vaccine pressure? , 2014, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[19]  M. Barreto,et al.  Effectiveness of rotavirus vaccine against hospitalized rotavirus diarrhea: A case-control study. , 2014, Vaccine.

[20]  Inacio Mandomando,et al.  Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study , 2013, The Lancet.

[21]  M. Kundi,et al.  Sustained low hospitalization rates after four years of rotavirus mass vaccination in Austria. , 2013, Vaccine.

[22]  J. Matthijnssens,et al.  Effectiveness of rotavirus vaccination in prevention of hospital admissions for rotavirus gastroenteritis among young children in Belgium: case-control study , 2012, BMJ : British Medical Journal.

[23]  K. Neuzil,et al.  Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine. , 2012, Vaccine.

[24]  Joseph H Abramson,et al.  WINPEPI updated: computer programs for epidemiologists, and their teaching potential , 2011, Epidemiologic perspectives & innovations : EP+I.

[25]  Benjamin A Lopman,et al.  Uptake, Impact, and Effectiveness of Rotavirus Vaccination in the United States: Review of the First 3 Years of Postlicensure Data , 2011, The Pediatric infectious disease journal.

[26]  G. Barnes,et al.  Distribution of Rotavirus Genotypes After Introduction of Rotavirus Vaccines, Rotarix® and RotaTeq®, into the National Immunization Program of Australia , 2011, The Pediatric infectious disease journal.

[27]  Manish M Patel,et al.  Sustained Decline in Rotavirus Detections in the United States Following the Introduction of Rotavirus Vaccine in 2006 , 2011, The Pediatric infectious disease journal.

[28]  S. Lambert,et al.  Reduction in Rotavirus-associated Acute Gastroenteritis Following Introduction of Rotavirus Vaccine Into Australia's National Childhood Vaccine Schedule , 2011, The Pediatric infectious disease journal.

[29]  E. Mendelson,et al.  Genotyping Rotavirus RNA from Archived Rotavirus-Positive Rapid Test Strips , 2011, Emerging infectious diseases.

[30]  R. Glass,et al.  United States Rotavirus Strain Surveillance From 2005 to 2008: Genotype Prevalence Before and After Vaccine Introduction , 2011, The Pediatric infectious disease journal.

[31]  M. Levine,et al.  Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial , 2010, The Lancet.

[32]  L. Shulman,et al.  Effectiveness of rotavirus vaccines for prevention of rotavirus gastroenteritis-associated hospitalizations in Israel: A case-control study , 2010, Human vaccines.

[33]  M. Iturriza-Gómara,et al.  Identification of G8 rotavirus strains determined as G12 by rotavirus genotyping PCR: updating the current genotyping methods. , 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[34]  P. Maes,et al.  RotaC: A web-based tool for the complete genome classification of group A rotaviruses , 2009, BMC Microbiology.

[35]  M. Kundi,et al.  Universal Mass Vaccination Against Rotavirus Gastroenteritis: Impact on Hospitalization Rates in Austrian Children , 2009, The Pediatric infectious disease journal.

[36]  L. Shulman,et al.  Incidence, characteristics, and economic burden of rotavirus gastroenteritis associated with hospitalization of israeli children <5 years of age, 2007-2008. , 2009, The Journal of infectious diseases.

[37]  Cécile Viboud,et al.  Demographic Variability, Vaccination, and the Spatiotemporal Dynamics of Rotavirus Epidemics , 2009, Science.

[38]  U. Wahn,et al.  Hospital-Based Surveillance to Estimate the Burden of Rotavirus Gastroenteritis Among European Children Younger Than 5 Years of Age , 2009, Pediatrics.

[39]  J. Matthijnssens,et al.  Evolutionary History and Global Spread of the Emerging G12 Human Rotaviruses , 2007, Journal of Virology.

[40]  T. Vesikari,et al.  Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. , 2006, The New England journal of medicine.

[41]  J. Heyse,et al.  Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. , 2006, The New England journal of medicine.

[42]  S. Ueda,et al.  Relative frequency of VP4 gene alleles among human rotaviruses recovered over a 10-year period (1982-1991) from Japanese children with diarrhea , 1993, Journal of clinical microbiology.

[43]  R. Glass,et al.  Identification of group A rotavirus gene 4 types by polymerase chain reaction , 1992, Journal of clinical microbiology.

[44]  R. Glass,et al.  Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens , 1990, Journal of clinical microbiology.